Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Boston Neurosciences

Boston Neurosciences
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of medical device company designed to non-invasively measure the absolute value of intracranial pressure (ICP), real-time cerebral blood flow autoregulation (CA) and intracranial volumetric wave monitoring. The company's ultrasound-based devices offers non-invasive ICP measurement for conditions such as traumatic brain injury, concussion, hydrocephalus, stroke, brain tumors, and other neurological diseases, enabling clinicians to obtain safer, faster, accurate and cost efficient measurements of absolute intracranial pressure values.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • K. Barsausko 59 - B814
  • Kaunas, LT-51423
  • Lithuania

+370 (8-614) 00000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Boston Neurosciences’s full profile, request a free trial.

Boston Neurosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 16-Oct-2015 $10M 0000 0000 Completed Startup
1. Grant 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Boston Neurosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Boston Neurosciences Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 00000000000 Venture Capital-Backed Pleasanton, CA 000000&0
To view this company’s complete list of competitors, request access »

Boston Neurosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Imprimatur Capital Venture Capital Minority 000 0000 000000 0
Start Capital Venture Capital Minority 000 0000 000000 0
Xeraya Capital Venture Capital Minority 000 0000 000000 0

Boston Neurosciences Executive Team (4)

Name Title Board
Seat
Contact
Info
Teo Dagi MD Board Member & Chief Executive Officer
Remis Bistras Ph.D President & Board Member
Edvardas Satkauskas General Director

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Boston Neurosciences Board Members (6)

Name Representing Role Since Contact
Info
Aditya Puri Xeraya Capital Board Member 000 0000
Aloyzas Petrikas Self Board Member 000 0000
Christopher Hunt Imprimatur Capital Board Member 000 0000
Edvardas Satkauskas Boston Neurosciences General Director 000 0000
Remis Bistras Ph.D Boston Neurosciences President & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »